Network origin in Johannes Streffer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Johannes Streffer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Suva City Council | Corporate Officer/Principal | ||
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| University of Tilburg | College/University | Corporate Officer/Principal | |
| University of Lausanne | College/University | Corporate Officer/Principal | |
| Richard Büchner Foundation | Director/Board Member | ||
| Swiss Society of Economics & Statistics | President | ||
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| Schweizerische Management Gesellschaft | Director/Board Member | ||
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Bern | College/University | Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ViiV Healthcare Co. | Corporate Officer/Principal | ||
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Oxford University Medical School | College/University | Doctorate Degree | |
Heidelberg Instruments Nano AG
 Heidelberg Instruments Nano AG Information Technology ServicesTechnology Services Heidelberg Instruments Nano AG designs and develops nanolithography technology. The firm offers NanoFrazor Systems, NanoFrazor Software. NanoFrazor Cantilevers, and NanoFrazor Resists. The company was founded by Felix Holzner and Philip Paul in 2012 and is headquartered in Zurich, Switzerland. | Information Technology Services | Director/Board Member | |
| University of Delaware | College/University | Undergraduate Degree | |
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| OXURION NV | Pharmaceuticals: Major | Chief Executive Officer | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director of Finance/CFO | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| Tibotec Pharmaceuticals | Director of Finance/CFO | ||
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Medical Specialties | Director of Finance/CFO | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| University of Zurich | College/University | Undergraduate Degree | |
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Switzerland | 22 |
| United States | 17 |
| United Kingdom | 5 |
| Netherlands | 3 |
| Fiji | 2 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 9 |
| Electronic Technology | 3 |
| Finance | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 46 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 15 |
| Chairman | 8 |
| Director of Finance/CFO | 6 |
Most connected contacts
| Insiders | |
|---|---|
| Alan Colowick | 30 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Thomas Graney | 11 |
| Monica Shaw | 8 |
| Peter Bollmann | 4 |
| Howard Donovan | 2 |
- Stock Market
- Insiders
- Johannes Streffer
- Company connections
